By Amy Grossman | Communications Manager
Following our active involvement in achieving the world's first regulatory approval of misoprostol for postpartum hemorrhage, Venture Strategies for Health and Development assisted in the preparation of the misoprostol clinical guidelines for physicians and nurses in Nigeria. These guidelines were recently approved by the Nigerian Family Ministry of Health after they convened a technical expert meeting.
The inclusion of misoprostol in the country's official clinical guidelines is a fundamental step towards ensuring that misoprostol is used at the facility level to control postpartum hemorrhage - excessive bleeding after childbirth.
Dissemination and sensitization on the newly approved clinical guidelines have begun for health care professionals throughout the country. These sensitization efforts are coinciding with ongoing training efforts to familiarize health care providers with Active Management of Third Stage Labor and the Judicious use of Misoprostol and distribution activities of the local distributor, Emzor.
Links:
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
